Dr. Leen Kawas Biological Insights at RBC Capital Markets Meeting
Dr. Leen Kawas provided insights and actionable intelligence at the February 2023 RBC Capital Markets Meeting, which was held to analyze the recent sluggishness experienced by biotech markets. Recently, the industry has begun regaining its commercial success due to efforts by stronger biotech firms that resisted the downturn – like Kawas’s company, Propel Bio Partners. Many of the problems have been attributed to the recent upsurge of newly organized biotech firms that have been shackled by regulatory and clinical trial issues.
Leen Kawas Examines Biotech Industry’s Positive Trends
Dr. Leen Kawas reminded the participants of continuing positive trends in biotech that include extreme innovation in the industry and some relaxation in the regulatory environment. Other positive industry trends include:
- Biotech Innovations
Companies have begun pursuing large-scale therapies like gene editing, using protein degradation, individual gene therapies and other advanced medical modalities. - Regulatory Changes
Changes in burdensome regulations are expected in 2023 including the relaxation of rules prohibiting the use of mixed and limited data. Gene therapies, which often involve orphan and rare diseases, are expected to pave the way. - Increased Mergers and Acquisitions
An increasingly favorable atmosphere for approving mergers and acquisitions will benefit the industry by triggering investments. This atmosphere ensures that industry will have the resources necessary to fund big projects.
Addressing Biotech Industry Problems
The major negative problems facing the industry include increased industry-wide competition, increased financing difficulties and a somewhat lukewarm investor attitude, which is based on slower returns. Dr. Leen Kawas encourages investors to stay the course to earn high dividends despite delays and regulatory problems. The returns on investments in the industry are often phenomenal, which justifies working harder to obtain financing and staying patient.